Comparison of Carcinoembryonic Antigen Levels Among Degree of Differentiation and Colorectal Cancer’s Location in Medan
DOI:
https://doi.org/10.3889/oamjms.2019.442Keywords:
Carcinoembryonic Antigen, Colorectal CarcinomaAbstract
BACKGROUND: The most widely used tumour markers, especially in colorectal malignancy, is Carcinoembryonic antigen (CEA).
AIM: This study was aimed to investigate CEA value among the degree of differentiation and tumour location.
METHODS: A cross-sectional analytical study was used in this study on eighty consecutive patients with colorectal carcinoma (CRC) at Adam Malik General Hospital and Permata Bunda Hospital, Medan, Indonesia. All data were analysed using SPSS for Windows version 21.
RESULTS: They were rectal cancer 49.4%, left-sided colon cancer 43.2% and right-sided colon cancer 6.2%. Histopathology findings were well-differentiated 40.7%, moderate differentiated 32.1% and poorly differentiated 25.9%. There were no correlations between CEA level and haemoglobin level, white blood cells count, and platelet count. There was no significant difference between CEA and location of the tumour (p = 0.70), although CEA level was significantly differenced among histopathology findings (p = 0.03). CEA levels were and associated with the degree of differentiation.
CONCLUSION: CEA levels increased in well-differentiated colorectal carcinoma especially in rectal cancer.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
American cancer. Cancer Facts & Fiqures 2017. Atlanta: American Cancer Society, 2012:1.
Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Anticancer research. 2000; 20(6D):5195-8.
Vukobrat-Bijedic Z, Husic-Selimovic A, Sofic A, Bijedic N, Bjelogrlic I, Gogov B, Mehmedovic A. Cancer antigens (CEA and CA 19-9) as markers of advanced stage of colorectal carcinoma. medical archives. 2013; 67(6):393-396, 2013. https://doi.org/10.5455/medarh.2013.67.397-401 PMid:25568506 PMCid:PMC4272469
GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012, 2012.
World Health Organization, Cancer Country Profiles Indonesia, 2014.
Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, Lamerz R, Peltomaki P, Sturgeon C, Topolcan O. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer. 2007; 43:1348-1360. https://doi.org/10.1016/j.ejca.2007.03.021 PMid:17512720
Norton JA. Carcinoembryonic Antigen, New Applications for an Old Marker. National Cancer Institute/NIH, Bethesda. 2017; 203:2.
M.Li, J.-Y, Li, A.-L, Zao, Comparison of carsinoembryonic antigen prognostic value in serum and tumor tissue of patients with colorectal cancer. 2018;11:276-281. https://doi.org/10.1111/j.1463-1318.2008.01591.x PMid:18513194 PMCid:PMC3002045
Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N. Carbohidrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci. 2014; 95(5):377-384. https://doi.org/10.1111/j.1349-7006.2004.tb03219.x PMid:15132763
Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clinical chemistry. 2000; 47(4):624-30.
Bin J, Xin W, Yan J, Wensen X, Bel C, Lin L, Zheng C, Liu H, Domping F. Detection of serum gastric cancer Associated MG7-Ag from gastric cancer patients using a sensitive and convenient ELISA Method. Cancer Investigation. 2015; 27:227-233. https://doi.org/10.1080/07357900802175609 PMid:19235597
Sudoyo AW, Hernowo B, Krisnuhoni E, Reksodiputro AH, Hardjodisastro D. Colorectal cancer among young native Indonesians: a clinicopathological and molecular assessment on microsatellite instability. Medical Journal of Indonesia. 2011; 19(4):245-51. https://doi.org/10.13181/mji.v19i4.411
Meyerhardt JA, Mangu PB, Flynn PJ, Korde L, Loprinzi CL, Minsky BD, Petrelli NJ, Ryan K, Schrag DH, Wong SL, Benson AB. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013; 31:4465-4470. https://doi.org/10.1200/JCO.2013.50.7442 PMid:24220554
Labianca R, Nordlinger B, Beretta GD, Mosconi S, Mandala M, Cervantes A, Arnold D. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013; 24(6):vi64-vi72. https://doi.org/10.1093/annonc/mdt354 PMid:24078664
Park JW, Chang HJ, Kim BC, Yeo HY, Kim DY. Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer. Colorectal Dis. 2013; 15:e503-e511. https://doi.org/10.1111/codi.12304 PMid:23711333
Nicholson BD, Shinkins B, Pathiraja I, Roberts NW, James TJ, Mallett S, Perera R, Primrose JN, Mant D. Blood CEA levels for detecting recurrent colorectal cancer. Cochrane Database Syst Rev. 2015; (12):CD011134. https://doi.org/10.1002/14651858.CD011134.pub2
Jeon BG, Shin R, Chung JK, Jung IM, Heo SC. Individualized cutoff value of the preoperative carcinoembryonic antigen level is necessary for optimal use as a prognostic marker. Ann Coloproctol. 2013; 29:106-14. https://doi.org/10.3393/ac.2013.29.3.106 PMid:23862128 PMCid:PMC3710771
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Gontar Alamsyah Siregar, Henry Sibarani (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
